https://www.justajournals.com/
Latest
Omeros (OMER) Streamlines Debt, Preps for Narsoplimab Launch
General Fri May 16 2025

Omeros (OMER) Streamlines Debt, Preps for Narsoplimab Launch

General
Summary: Omeros Corporation (OMER, Financial) reduces 2026 debt by $10 million, extending maturity to 2029. Focuses on capital for possible FDA approval and m... Summary: Omeros Corporation (OMER) reduces 2026 debt by $10 million, extending maturity to 2029. Focuses on capital for possible FDA approval and market Read More
Related